Robert Gibson

Director/Board Member at SCOPUS BIOPHARMA INC.

46 year

Finance

Consumer Services

Health Technology

Profile

Robert J.
Gibson is Vice Chairman at Scopus Biopharma, Inc. since 2017.
Mr. Gibson is Co-Chairman at Hcfp.
Mr. Gibson is Executive Vice President at HCFP LLC.
Formerly, Mr. Gibson was an Analyst at Bear, Stearns & Co., Inc. Mr. Gibson was Vice President at CRT Capital Group LLC in 2009.
Mr. Gibson was Senior Vice President at First New England Capital.
Mr. Gibson was Senior Vice President at Balance Point Capital Partners LP.
Mr. Gibson completed undergraduate studies at Amherst College.

Robert Gibson active positions

Companies	Position	Start
SCOPUS BIOPHARMA INC.	Director/Board Member	2017-04-17
HCFP LLC HCFP LLC Financial ConglomeratesFinance Provides financial and accounting resources	Corporate Officer/Principal	-
Hcfp/Capital Markets LLC	Chairman	-

All active positions of Robert Gibson

Former positions of Robert Gibson

Companies	Position	End
CRT Capital Group LLC CRT Capital Group LLC Investment Banks/BrokersFinance Provides brokerage services	Corporate Officer/Principal	2009-02-27
Balance Point Capital Partners LP Balance Point Capital Partners LP Investment ManagersFinance Acts as Private Equity Fund	Corporate Officer/Principal	-
Bear, Stearns & Co., Inc. Bear, Stearns & Co., Inc. Investment Banks/BrokersFinance Provides investment banking, securities trading and brokerage Services	Corporate Officer/Principal	-
First New England Capital First New England Capital Investment ManagersFinance First New England Capital (FNEC) invests in mezzanine and equity securities of middle market, later-stage companies across a variety of industries that have generated $10 million to $150 million of revenue and have demonstrated an ability to deliver strong operating performance and cash flow. They also consider investments in dynamic, fast-growing companies with a demonstrated ability to execute well-defined operating strategies. The firm seeks companies which have demonstrated a balance between sustainable growth and expense control. The firm prefers to invest in transactions that range in size from $2 million to $7 million. They may also make smaller investments in companies that have the potential for follow-on investment or larger investments in combination with other investment partners. Investments may be structured as current pay and/or payment-in-kind securities, preferred stock or common equity in conjunction with mezzanine capital. FNEC's capital is typically used to provide liquidity to founders and existing shareholders, to make acquisitions or finance organic growth. They will act as lead or participate as a member of larger syndicates. FNEC is often a minority investor. In most investments, FNEC requires board representation.	Private Equity Analyst	2010-05-23

See the detail of Robert Gibson's experience

Training of Robert Gibson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert Gibson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
Bear, Stearns & Co., Inc. Bear, Stearns & Co., Inc. Investment Banks/BrokersFinance Provides investment banking, securities trading and brokerage Services	Finance
Balance Point Capital Partners LP Balance Point Capital Partners LP Investment ManagersFinance Acts as Private Equity Fund	Finance
CRT Capital Group LLC CRT Capital Group LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Amherst College Amherst College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
First New England Capital First New England Capital Investment ManagersFinance First New England Capital (FNEC) invests in mezzanine and equity securities of middle market, later-stage companies across a variety of industries that have generated $10 million to $150 million of revenue and have demonstrated an ability to deliver strong operating performance and cash flow. They also consider investments in dynamic, fast-growing companies with a demonstrated ability to execute well-defined operating strategies. The firm seeks companies which have demonstrated a balance between sustainable growth and expense control. The firm prefers to invest in transactions that range in size from $2 million to $7 million. They may also make smaller investments in companies that have the potential for follow-on investment or larger investments in combination with other investment partners. Investments may be structured as current pay and/or payment-in-kind securities, preferred stock or common equity in conjunction with mezzanine capital. FNEC's capital is typically used to provide liquidity to founders and existing shareholders, to make acquisitions or finance organic growth. They will act as lead or participate as a member of larger syndicates. FNEC is often a minority investor. In most investments, FNEC requires board representation.	Finance
HCFP LLC HCFP LLC Financial ConglomeratesFinance Provides financial and accounting resources	Finance
Scopus Biopharma, Inc. Scopus Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company develops transformational therapeutics for serious diseases	Health Technology
Hcfp/Capital Markets LLC	Finance